Signs and Symptoms, Digestive  >>  fosaprepitant  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fosaprepitant / Generic mfg.
NCT01874119: Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma

Terminated
2b
13
US
Fosaprepitant, Emend
St. Louis University, Merck Sharp & Dohme LLC
Chemotherapy-induced Nausea and Vomiting
12/15
12/15
NCT01405924: Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)

Terminated
2
111
NA
Fosaprepitant dimeglumine, MK-0517, EMEND® IV, 5-HT3 RA, Dexamethasone, Rescue medication
Merck Sharp & Dohme LLC
Nausea, Vomiting
12/13
12/13

Download Options